| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/20/2008 | EP1957469A1 Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| 08/20/2008 | EP1957468A2 Polyalkylene glycol derivatives of 4 - (phenylamino)quinazolines useful as irreversible inhibitors of epidermal growth factor receptor tyrosine kinase |
| 08/20/2008 | EP1957466A1 4-aminopyrimidine-5-thione-derivatives for the treatment of cancer |
| 08/20/2008 | EP1957460A1 Bicyclic compounds with kinase inhibitory activity |
| 08/20/2008 | EP1957115A1 Method of treating ovarian and renal cancer using antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen |
| 08/20/2008 | EP1957077A2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 08/20/2008 | EP1957074A2 Formulations of quinolinones |
| 08/20/2008 | EP1957073A2 Medicinal drug |
| 08/20/2008 | EP1957069A2 Treatment of cancers with acquired resistance to kit inhibitors |
| 08/20/2008 | EP1957065A1 Estrogen cancer therapy |
| 08/20/2008 | EP1957060A2 Cancer treatment using fts and 2-deoxyglucose |
| 08/20/2008 | EP1957056A2 Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| 08/20/2008 | EP1750716B1 Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 08/20/2008 | EP1742947B1 6-substituted pyridoindolone derivatives production and therapeutic use thereof |
| 08/20/2008 | EP1667947B1 Methods of 11c -radiolabelling phenothiazine and pheno thiazine-like compounds |
| 08/20/2008 | EP1666880B1 Screening method |
| 08/20/2008 | EP1654349A4 Sulfs as modifiers of the beta catenin pathway and methods of use |
| 08/20/2008 | EP1651956A4 Melks as modifiers of the rac pathway and methods of use |
| 08/20/2008 | EP1616873B1 Lipid-regulating agent and use thereof |
| 08/20/2008 | EP1546188B1 P53 binding t cell receptor molecules and uses thereof |
| 08/20/2008 | EP1509521B1 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases |
| 08/20/2008 | EP1509223B1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1453812B1 Cytotoxic agents |
| 08/20/2008 | EP1446500B1 A method for regulating immune function in primates using the foxp3 protein |
| 08/20/2008 | EP1428530B1 Tetrapeptide derivative crystals |
| 08/20/2008 | EP1356052B1 Production of full antibodies in procaryotic cells |
| 08/20/2008 | EP1333850B1 Use of il-13 inhibitors for the treatment of tumors |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1228210B1 A method for detecting prostate cancer |
| 08/20/2008 | EP1221445B1 Pentacyclic taxane compounds |
| 08/20/2008 | EP1198589B1 Tenascin-c nucleic acid ligands |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | CN101248180A Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers |
| 08/20/2008 | CN101248177A Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same |
| 08/20/2008 | CN101248105A Polymer conjugates of K-252a and derivatives thereof |
| 08/20/2008 | CN101248080A Inhibitors of VEGF receptor and HGF receptor signaling |
| 08/20/2008 | CN101248078A Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 08/20/2008 | CN101248072A 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 08/20/2008 | CN101248063A Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 08/20/2008 | CN101248062A C-fms kinase inhibitors |
| 08/20/2008 | CN101248056A Non-steroidal progesterone receptor modulators |
| 08/20/2008 | CN101248046A Amide derivatives as kinase inhibitors |
| 08/20/2008 | CN101247837A Novel salts of conjugated psychotropic drugs and processes of preparing same |
| 08/20/2008 | CN101245318A Artificial cultivation method of Basidiomycetes and uses thereof |
| 08/20/2008 | CN101245317A Process for producing honeysuckle flower Xanthochrous nilgheriensis (Mont.) Teng and application for medicine |
| 08/20/2008 | CN101245112A Polyoses extracted from pistacia chinensis meal and extracting method thereof |
| 08/20/2008 | CN101245109A Polyglycol single-modificatory recombined human granular leukocyte colony stimulating factor mutant and preparation method thereof |
| 08/20/2008 | CN101245107A Antihuman transferrin acceptor human source antibody and uses thereof |
| 08/20/2008 | CN101245106A Anti-VRGF acceptor monoclone antibody, preparation method and application thereof |
| 08/20/2008 | CN101245101A Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146 |
| 08/20/2008 | CN101245092A Novel antineoplastic compound Ananaside C in thelenota ananas |
| 08/20/2008 | CN101245091A Novel antineoplastic compound Ananaside B in thelenota ananas |
| 08/20/2008 | CN101245090A 3,6-di-substituted sterides oximes compound as antineoplastic medicament |
| 08/20/2008 | CN101245089A Process for producing a pair of novel ginsengenin and its compound body, and preparations thereof |
| 08/20/2008 | CN101245083A Platinum complex containing 1,3-dioxolane structure, synthesizing process and uses thereof |
| 08/20/2008 | CN101245061A N-(5-amido-2-methyl phenyl)-4-(3-pyridinyl)-2-aminopyrimidine nitric oxide donating derivant, production method and uses thereof |
| 08/20/2008 | CN101245050A 4-aniline quinazoline derivative salt |
| 08/20/2008 | CN101245048A Antineoplastic compound of red pineapple flower alkali A, preparation method and application thereof |
| 08/20/2008 | CN101244991A Method for extracting and purifying sequoyitol by using solvent deposition |
| 08/20/2008 | CN101244274A Ferrite/bacille calmette-guerin vaccine/temperature sensing gel rubber integration material and preparation thereof |
| 08/20/2008 | CN101244272A Anti-solid tumors pharmaceutical combination containing topological enzyme inhibitor |
| 08/20/2008 | CN101244271A Anti-solid tumors pharmaceutical combination containing topological enzyme inhibitor |
| 08/20/2008 | CN101244255A Thymus gland pentapeptide injection and uses thereof |
| 08/20/2008 | CN101244228A Brazilian mushroom lozenge composition and method of making the same |
| 08/20/2008 | CN101244220A Black thorn chinaroot greenbrier total saponin extract and preparation thereof |
| 08/20/2008 | CN101244153A Application of alkekengi in preparing medicament for treating digestive system disease, product and preparation |
| 08/20/2008 | CN101244111A Preparation of salidroside and application of the same in medicine field |
| 08/20/2008 | CN101244105A Pseudo-ginseng standard extract P1237, its pharmaceutical combination, its preparing method and its uses |
| 08/20/2008 | CN101244104A Method for increasing rare saponin content in panax ginseng total saponin extract |
| 08/20/2008 | CN101244102A Panax ginseng vinegar preparation as adjuvant for treating cancer |
| 08/20/2008 | CN101244100A Method for preparing extract of shoulder pole tegument and antineoplastic use of the same |
| 08/20/2008 | CN101244097A Extended release formulation containing acidic active component of gamboge |
| 08/20/2008 | CN101244094A Compound preparation for preventing cancer and reinforcing immunity, and preparation method |
| 08/20/2008 | CN101244085A Preparation of sea cucumber total saponin and application in medicine field |
| 08/20/2008 | CN101244078A Medicament for treating hemangioma and preparation thereof |
| 08/20/2008 | CN101244067A Application of 23-hydroxyl radical betulic acid in preparing reversal agent multidrug resistance of cancer cell |
| 08/20/2008 | CN101244061A Application of two alkaloid compounds in preparing antineoplastic medicaments |
| 08/20/2008 | CN101244056A Combination capable of preventing prostate gland cancer |
| 08/20/2008 | CN101244055A Application of oroxylin in pharmacy |
| 08/20/2008 | CN101244054A Application of oridonin in preparing medicaments for promoting surrounding vascellum tunica interna incrassation |
| 08/20/2008 | CN101244053A Novel dispersed system with docetaxel as main component |
| 08/20/2008 | CN101244048A Chalcone compounds and uses of the composition |
| 08/20/2008 | CN101244039A Novel method for preparing indissoluble medicaments liposome preparations |
| 08/20/2008 | CN101244036A High dispersion does type containing cholesterol group phosphoryl nucleoside analogue |
| 08/20/2008 | CN101244034A Sustained-release agent containing taxone and its synergistic agent |
| 08/20/2008 | CN101244032A Transdermal fluid |
| 08/20/2008 | CN101244030A Anticancer sustained-release injection containing estrogen receptor antagon |
| 08/20/2008 | CN101244029A Anticancer sustained-release injection containing estrogen receptor antagon |
| 08/20/2008 | CN100412193C Anti human CD19 mouse immune globulin variable zone gene and uses |
| 08/20/2008 | CN100412090C Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/20/2008 | CN100412086C Glycopeptide compositions |
| 08/20/2008 | CN100412085C Bc-2 antisense thiophosphoric acid oligodeoxynucleotides anticancer drugs, preparing method and uses thereof |
| 08/20/2008 | CN100412076C New benzodioxino-isoindole derivatives, useful for treatment of cancer, are inhibitors of cell cycle |
| 08/20/2008 | CN100412066C Compounds and compositions as protein kinase inhibitors |
| 08/20/2008 | CN100412063C Polymorphous form of rimonabant, preparation method and pharmaceutical compositions containing same |
| 08/20/2008 | CN100411689C Use of ShRNA for suppressing telomere enzyme reverse transcriptase hTERT expression in antineoplastic action |
| 08/20/2008 | CN100411688C Medicine composition containing cyclodextrin/polyene taxol and its preparation process |
| 08/20/2008 | CN100411684C Use of FVIIa or tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 08/20/2008 | CN100411634C Medication for treating liver disease, and preparation method |